Ocular hypotensive effects of melatonin receptor agonists in the rabbit: Further evidence for an MT 3 receptor

British Journal of Pharmacology

Volumn 138, Issue 5, 2003, Pages 831-836

  Pintor, Jesus ^a   Peláez, Teresa ^a   Hoyle, Charles H V ^b   Peral, Assumpta ^c  

^a Depto de Bioquim y Biol Molec IV   (Spain)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c Depto de Optica EU Optica   (Spain)

Author keywords

5 methoxycarbonylamino N acetyltryptamine (5 MCA NAT); Glaucoma; Intraocular pressure; Melatonin; Ocular hypertension

Indexed keywords

2 IODOMELATONIN; 2 PHENYLMELATONIN; 3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; 5 METHOXYCARBONYLAMINO N ACETYLTRYPTAMINE; 6 CHLOROMELATONIN; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ATROPINE; BETA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORYNANTHINE; DH 97; HEXAMETHONIUM; MELATONIN; MELATONIN DERIVATIVE; MELATONIN MT3 RECEPTOR; MELATONIN RECEPTOR; MELATONIN RECEPTOR AGONIST; MELATONIN RECEPTOR ANTAGONIST; N ACETYLTRYPTAMINE; PRAZOSIN; RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG; YOHIMBINE;

ANIMAL EXPERIMENT; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CHOLINERGIC SYSTEM; CIRCADIAN RHYTHM; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; INTRAOCULAR HYPOTENSION; INTRAOCULAR PRESSURE; MALE; NONHUMAN; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; RABBIT; REGULATORY MECHANISM;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MELATONIN; OCULAR HYPOTENSION; RABBITS; RECEPTORS, CELL SURFACE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, MELATONIN; TRYPTAMINES;

EID: 0037351462     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705118     Document Type: Article

References (30)

1. BARTNESS, T.J. & GOLDMAN, B.D. (1989). Mammalian pineal melatonin: a clock for all seasons. Experientia, 45, 939-945.
2. BENITEZ-KING, G., HUERTO-DELGADILLO, L. & ANTON-TAY, F. (1990). Melatonin effects on the cytoskeletal organization of MDCK and neuroblastoma N1E-115 cells. J. Pineal. Res., 9, 209-220.
3. 125I]iodomelatonin binding sites in mammalian retina. J. Neurochem., 56, 1873-1880.
4. BOJANOWSKA, E. & FORSLING, M.L. (1997). The effects of melatonin on vasopressin secretion in vivo: interactions with acetylcholine and prostaglandins. Brain Res. Bull., 42, 457-461.
5. 1-adrenoceptor antagonist, lowers intraocular pressure in NZW rabbits. Current Eye Res., 23, 144-153.
6. CHU, T., OGIDIGBEN, M.J. & POTTER, D.E. (1999). 8OH-DPAT-Induced ocular hypotension: sites and mechanisms of action. Exp. Eye Res., 69, 227-238.
7. CUTLER, N.L., HUGHES, R.J., SINGER, C.M., SACK, R., MOTIFF, M.T. & LEWY, A.J. (1997). Insomnia in older individuals: is early morning awakening the main problem? Sleep Res., 26, 348-355.
8. DJAMGOZ, M.B. & WAGNER, H.J. (1992). Localization and function of dopamine in the adult vertebrate retina. Neurochem. Int., 20, 139-191.
9. DUBOCOVICH, M.L. (1995). Melatonin receptors: are there multiple subtypes? Trends Pharmacol. Sci., 16, 50-56.
10. LAITINEN, T.J. & SAAVEDRA, J.M. (1990). The chick retinal melatonin receptor revisited: localization, modulation of agonist binding with guanine nucleotides. Brain Res., 528, 349-352.
11. LIU, J.H. & DACUS, A.C. (1991). Aqueous humor cyclic AMP and circadian elevation of intraocular pressure in rabbits. Curr. Eye Res., 10, 1175-1177.
12. 4 and melatonin receptors. Br. J. Pharmacol., 121, 1775-1781.
13. MARTIN, X.D., MALINA, H.Z., BRENNAN, M.C., HENDRICKSON, P.H. & LICHTER P.R. (1992). The ciliary body, the third organ found to synthesise indoleamines in humans. Eur. J. Ophthalmol., 2, 67-72.
14. MULLINS, U.L., FERNANDES, P.B. & EISON, A.S. (1997). Melatonin agonists induce phosphoinositide hydrolysis in Xenopus laevis melanophores. Cell. Signal., 9, 169-173.
15. 3 as the quinone reductase 2. J. Biol. Chem., 275, 31311-31317.
16. 2. Biochem. Pharmacol., 61, 1369-1379.
17. OSBORNE, N.N. & CHIDLOW, G. (1994). The presence of functional melatonin receptors in the iris-ciliary processes of the rabbit eye. Exp. Eye Res., 59, 3-9.
18. PAREDES, D., RADA, P., BONILLA, E., GONZALEZ, L.E., PARADA, M. & HERNANDEZ, L. (1999). Melatonin acts on the nucleus accumbens to increase acetylcholine release and modify the motor activity pattern of rats. Brain. Res., 850, 14-20.
19. 125I]iodomelatonin binding sites in Syrian hamster peripheral organs. J. Pharmacol. Exp. Ther., 290, 334-340.
20. 3 receptors in the regulation of intraocular pressure in rabbits. Eur. J. Pharmacol., 416, 251-254.
21. PINTOR, J. & PERAL, A. (2000). Therapeutic potential of nucleotides in the eye. Drug Develop Res., 52, 190-195.
22. RAGHAVENDRA, V. & KULKARNI, SK. (1999). Reversal of morphine tolerance and dependence by melatonin: possible role of central and peripheral benzodiazepine receptors. Brain Res., 834, 178-181.
23. REITER, R.J., TAN, D.X., OSUNA, C. & GITTO, E. (2000). Actions of melatonin in the reduction of oxidative stress. A review. J. Biomed. Sci., 7, 444-458.
24. SAMPLES, J.R., KRAUSE, G. & LEWY, A.J. (1988). Effect of melatonin on intraocular pressure. Curr. Eye Res., 7, 649-653.
25. SUGIYAMA, T., KIDA, T., MIZUNO, K., KOJIMA, S. & IKEDA, T. (2001). Involvement of nitric oxide in the ocular hypotensive action of nipradilol. Curr. Eye Res., 23, 346-351.
26. TORIS, C.B., GLEASON, M. & CAMRAS, C.B. (1995a). Effects of brimonidine on aqueous humor dynamics in human eyes. Arch. Ophthalmology, 113, 1514-1517.
27. TORIS, C.B., TAFOYA, M.E. & CAMRAS, C.B. (1995b). Effects of apraclonidine on aqueous humor dynamics in human eyes. Ophthalmol., 41, S41-S47.
28. WIECHMANN A.F. & WIRSIG-WIECHMANN, C.R. (2001). Melatonin receptor mRNA and protein expression in Xenopus laevis non-pigmented ciliary epithelial cells. Exp. Eye Res., 73, 617-623.
29. YU, H.S., YEE, R.W., HOWES, K.A. & REITER, R.J. (1990). Diurnal rhythms of immunoreactive melatonin in the aqueous humor and serum of male pigmented rabbits. Neurosci. Lett., 116, 309-314.
30. YU, C-X., ZHU, C.-B, XU, S.-F., CAO, X.-D. & WU, G.-C. (2000). The analgesic effects of peripheral and central administration of melatonin in rats Eur. J. Pharmacol., 403, 49-53.